Miprogen-SR 200 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Miprogen-SR 200 mg Tablet contains progesterone, a natural female sex hormone, in a sustained-release oral form. Its labelling describes it for menstrual and pregnancy-related problems caused by hormonal imbalance, for supporting female fertility by preparing the lining of the uterus for pregnancy, and as part of hormone replacement therapy to prevent endometrial hyperplasia and relieve menopausal symptoms. It is taken with food at the same time each day.
Product Information
The following description reflects information associated with progesterone and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for menstrual and pregnancy-related problems caused by hormonal imbalance
- Described for supporting female fertility by preparing the lining of the uterus for pregnancy
- Described as part of hormone replacement therapy to prevent endometrial hyperplasia
- Described as relieving menopausal symptoms such as hot flushes, night sweats, vaginal dryness, mood swings, and reduced sex drive
Described Dosage & Administration
- Swallowed whole with food, at about the same time each day; tablets should not be broken, chewed, or crushed
- Taken exactly as instructed by the doctor, without stopping before the course is complete
Described Side Effects
Commonly described side effects include:
- Nausea and vomiting
- Abdominal pain and bloating
- Vaginal yeast infection
- Abnormal vaginal bleeding or spotting between periods
- Swelling (oedema)
- Hair loss
- Headache
- Breast pain
Spotting or bleeding between periods is described as possible; if it happens frequently, the doctor should be consulted. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- A complete medical history should be shared with the doctor
- Tests to check the womb may be carried out before and during treatment and should be cooperated with
- Alcohol and smoking should be avoided during treatment
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains progesterone and is used for menstrual and pregnancy-related problems caused by hormonal imbalance, for supporting female fertility, and as part of hormone replacement therapy to prevent endometrial hyperplasia. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole with food at about the same time each day, and not broken, chewed, or crushed. The course should be completed as prescribed.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.